Chemotherapy can increase mutation burden and change the cell population structure of normal blood, which contributes to long-term adverse effects such as second malignancies and infertility, ...

A groundbreaking drug, blinatumomab, is transforming leukemia treatment, offering new hope for patients like 4-year-old Madi Seivert.

Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the ...

Two years ago, Grafton learned he had stage 4 lung cancer. But thanks to a clinical trial at Duke funded by the National ...

Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the ...

A common anti-nausea drug used during chemotherapy may do more than ease discomfort, it could help women with aggressive ...

Small cell lung cancer (SCLC), one of the deadliest types of lung cancer, is an aggressive tumor that metastasizes early compared to other cancers and can quickly develop resistance to chemotherapy — ...

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid leukemia ...

New preclinical research shows a promising drug combination that targets ovarian cancer’s survival pathways, paving the way ...

Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.

Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to ...